National Institute of Pharmaceutical Education and Research, S.A.S. Nagar

What are the cutoffs for National Institute of Pharmaceutical Education and Research, S.A.S. Nagar in 2026?

For 2026, admission to National Institute of Pharmaceutical Education and Research, S.A.S. Nagar is decided solely by your NIPER JEE 2026 merit rank, with no GATE or CAT route for the master's programmes. The headline closing rank for the General category sits inside the top 250 NIPER JEE All India Ranks across all MS (Pharm) and MBA (Pharm) seats, and the most competitive branch, Pharmacology, is expected to close near AIR 35-40. NIPER JEE is the only accepted entrance exam, and a valid GPAT score (qualifying marks of 40 and above for Unreserved, 35 and above for OBC/EWS/SC/ST/PwBD in 2024) is required to be eligible before your NIPER JEE rank is even considered.

In practical terms, an aspirant targeting National Institute of Pharmaceutical Education and Research, S.A.S. Nagar should aim for roughly 80+ marks out of 200 in NIPER JEE to stay within the top 100 ranks. The exam itself is 200 MCQs in 2 hours with 0.25 negative marking per wrong answer, and the institute fills its branch-wise seats in descending order of rank during counselling rounds, so the closing ranks below represent the last admitted candidate per branch and category.

Year-Wise Cutoff Trends (2024-2026)

The table below tracks the General-category NIPER JEE closing ranks at National Institute of Pharmaceutical Education and Research, S.A.S. Nagar for its flagship branches across 2024, 2025 and 2026, alongside OBC, SC and ST figures for 2025 where category data is available. It answers the core question every aspirant asks: "what was the last rank admitted to my branch and category?" Read each row as the closing (worst admitted) rank, not the opening rank, so your own NIPER JEE rank should be at or below the number shown to be safe. The 2026 column reflects the expected tightening flagged by counselling trackers and should be treated as a projection until official 2026 counselling closes.

The clear takeaway is that the General-category cutoff at National Institute of Pharmaceutical Education and Research, S.A.S. Nagar has steadily tightened: Pharmacology moved from AIR 50 (2024) to 45 (2025) and is projected to close near 35-40 in 2026, while Pharmaceutics firmed from 85 to 80 over the same window. Reserved-category candidates get meaningful relaxation, with 2025 OBC closing roughly double the General rank and SC/ST ranks extending into the high hundreds. The direction of travel is unambiguous, so a 2026 aspirant should plan for a slightly sharper cutoff than 2025 rather than a softer one.

Course-Wise Cutoff at National Institute of Pharmaceutical Education and Research, S.A.S. Nagar

National Institute of Pharmaceutical Education and Research, S.A.S. Nagar runs several MS (Pharm) specialisations plus an MBA (Pharm), and each closes at a different NIPER JEE rank because seat counts and demand vary by branch. The table below breaks down the 2025 General and OBC closing ranks programme by programme, answering "which branch is the toughest and which is the most accessible?" Read it top to bottom as a difficulty ladder: the lower the closing rank, the more competitive the branch. Use it to pick realistic branch preferences in your counselling choice-filling order.

The branch-wise spread shows Pharmacology as the hardest seat to win at National Institute of Pharmaceutical Education and Research, S.A.S. Nagar (General AIR 45 in 2025), followed by Pharmaceutics and Biotechnology, which reflect strong R&D and core-formulation demand. At the other end, Regulatory Toxicology (AIR 250) and MBA (Pharm) (AIR 220) are the most accessible, making them sensible safety choices for candidates ranked between 150 and 250. OBC candidates consistently get a 50-200 rank cushion over General across every branch shown.

Cutoff Trend Analysis

The cutoff at National Institute of Pharmaceutical Education and Research, S.A.S. Nagar is rising (the closing ranks are getting smaller year on year), which means admission is becoming harder, not easier. Pharmacology compressed from AIR 50 in 2024 to 45 in 2025 to a projected 35-40 in 2026, and the broad General band has shifted from closing under AIR 250 toward closing under AIR 220-250 with the top branches well inside the top 100. The drivers are structural: a fixed, small seat matrix per specialisation, a growing pool of GPAT-qualified B.Pharm graduates competing for the same MS (Pharm) seats, and the institute's strong standing among India's NIPER network (NIPER Mohali was ranked 9th in the NIRF 2024 Pharmacy list), which keeps demand high. Realistically, a General-category candidate needs an NIPER JEE AIR inside the top 80-100 (roughly 80+ marks out of 200) to be confident of a core branch like Pharmacology or Pharmaceutics, while a rank up to AIR 200-250 keeps branches such as Pharmaceutical Analysis, MBA (Pharm) and Regulatory Toxicology in play. OBC aspirants should target the top 150-350 and SC/ST aspirants the top 300-1,200 depending on branch, in line with the 2025 closing ranks.